机构：[1]Sichuan Univ, Dept Hematol, West China Hosp, Chengdu, Peoples R China四川大学华西医院[2]Zigong First Peoples Hosp, Dept Hematol, Zigong, Sichuan, Peoples R China[3]Sichuan Canc Hosp, Dept Oncol, Chengdu, Peoples R China四川省肿瘤医院
This report shows the contribution of metagenomic next-generation sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report two leukemia patients who developed severe infections due to carbapenem-resistant Klebsiella pneumoniae (CrKP). The mNGS can be strongly recommended as an alternative investigation for patients who are at high risk of infection without positivity on body fluid culture. This can provide the opportunity for adequate therapy.
基金：
1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University, China [2020HXFH020]
第一作者机构：[1]Sichuan Univ, Dept Hematol, West China Hosp, Chengdu, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Tao Huan,Hua Fang,Chen Yingying,et al.Metagenomic Next-Generation Sequencing (mNGS) for the Timely Diagnosis of Carbapenem-Resistant Klebsiella pneumoniae in Leukemia Patients[J].CASE REPORTS IN INFECTIOUS DISEASES.2022,2022:doi:10.1155/2022/6957028.
APA：
Tao, Huan,Hua, Fang,Chen, Yingying&Jia, Yongqian.(2022).Metagenomic Next-Generation Sequencing (mNGS) for the Timely Diagnosis of Carbapenem-Resistant Klebsiella pneumoniae in Leukemia Patients.CASE REPORTS IN INFECTIOUS DISEASES,2022,
MLA：
Tao, Huan,et al."Metagenomic Next-Generation Sequencing (mNGS) for the Timely Diagnosis of Carbapenem-Resistant Klebsiella pneumoniae in Leukemia Patients".CASE REPORTS IN INFECTIOUS DISEASES 2022.(2022)
